Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bonichon

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Bulletin Du Cancer|May 23, 2006
[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus]P Bourguet, A Hitzel, G Houvenaeghel, et al.
Breast Cancer Research and Treatment|May 1, 1988
Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF + tamoxifen in a single centreL Mauriac, M Durand, J Chauvergne, et al.
Breast Cancer Research and Treatment|September 3, 1999
Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 casesP Rudolph, G MacGrogan, F Bonichon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensityB N Bui, B Chevallier, C Chevreau, et al.
Breast Cancer Research and Treatment|August 15, 2000
Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerationsI de Mascarel, F Bonichon, G MacGrogan, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Expression of the GST pi gene and response to tamoxifen therapy in locally advanced breast carcinomasF Dorion-Bonnet, N Quénel, J M Coindre, et al.
International Journal of Cancer|January 15, 1984
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemM Trojani, G Contesso, J M Coindre, et al.
Cancer|May 1, 1996
Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysisV Le Doussal, J M Coindre, A Leroux, et al.
Cancer|May 11, 2001
Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma GroupJ M Coindre, P Terrier, L Guillou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trialA Ravaud, C Chevreau, L Cany, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Bulletin Du Cancer|May 23, 2006
[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus]P Bourguet, A Hitzel, G Houvenaeghel, et al.
Breast Cancer Research and Treatment|May 1, 1988
Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF + tamoxifen in a single centreL Mauriac, M Durand, J Chauvergne, et al.
Breast Cancer Research and Treatment|September 3, 1999
Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 casesP Rudolph, G MacGrogan, F Bonichon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensityB N Bui, B Chevallier, C Chevreau, et al.
Breast Cancer Research and Treatment|August 15, 2000
Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerationsI de Mascarel, F Bonichon, G MacGrogan, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Expression of the GST pi gene and response to tamoxifen therapy in locally advanced breast carcinomasF Dorion-Bonnet, N Quénel, J M Coindre, et al.
International Journal of Cancer|January 15, 1984
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading systemM Trojani, G Contesso, J M Coindre, et al.
Cancer|May 1, 1996
Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysisV Le Doussal, J M Coindre, A Leroux, et al.
Cancer|May 11, 2001
Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma GroupJ M Coindre, P Terrier, L Guillou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trialA Ravaud, C Chevreau, L Cany, et al.
Pageof 11